Ondansetron Tablet, Orally Disintegrating
Product Images NDC 70518-4685

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 70518-4685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Ondansetron 8 mg orally disintegrating tablets packaging label shows a quantity of 6 tablets. The label includes NDC number 70518-4685-00 and notes repackaging by RemedyRepack Inc., Indiana, PA. Manufacturer Glenmark, Mahwah, NJ is also mentioned. Storage instructions and dosage advice to see insert are included.*
FDA Label Image

Structure-base (Structure Base)

Structure-base (Structure Base)
Chemical structure of ondansetron showing its molecular arrangement including aromatic rings, ketone group, and methyl-substituted heterocyclic rings.*
FDA Label Image

Structure-hcl (Structure HCl)

Structure-hcl (Structure HCl)
Chemical structure of ondansetron hydrochloride dihydrate, showing its molecular arrangement including rings, nitrogen atoms, methyl groups, and oxygen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.